A consensus report by the American Diabetes Association (ADA) and the European Association for the study of Diabetes (EASD)
Researchers across gastroenterology, orthopaedics, neuroscience, and pharmacology have explored the compound's interaction with multiple biological pathways
Originally developed to help manage Type 2 diabetes, these medications have shown significant promise in the weight loss space, helping patients feel fuller longer, reduce cravings, and control portion sizes
Results reveal whether your plateau is driven by receptor insensitivity, appetite regulation genes, or energy expenditure factorsguiding whether you should increase tirzepatide, add semaglutide, or adjust lifestyle factors for maximum effect
Sourcing note: All patient names, testimonials, and outcome figures in this section are reproduced from Sunlight's publicly published website and marketing materials